Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
27 Sep 2014 ESMO 2014: Results of LUX-Lung 8, the Largest Prospective Trial to Compare EGFR TKIs in Patients with Relapsed/Refractory Squamous Cell Carcinoma of the Lung Lung and other thoracic tumours - Anticancer agents & Biologic therapy
27 Sep 2014 ESMO 2014 Press Release: Customising Chemotherapy in Lung Cancer: New Phase II Data Reported in Two Late-Breaking Studies Translational research - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
27 Sep 2014 ESMO 2014 Press Release: Docetaxel or Pemetrexed in Addition to Cisplatin Achieve Comparable Outcomes in Non-Squamous Lung Cancer Lung and other thoracic tumours - Anticancer agents & Biologic therapy
27 Sep 2014 ESMO 2014: Rolapitant Plus Granisetron/Dexamethasone in Prevention of Chemotherapy-Induced Nausea and Vomiting Palliative and supportive care
27 Sep 2014 ESMO 2014 Press Release: Immune Checkpoint Inhibitors Provide Antitumour Activity Across Malignant Diseases Immuno-oncology
27 Sep 2014 ESMO 2014: Afatinib vs Methotrexate in Second-Line Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma Head and neck cancers - Anticancer agents & Biologic therapy
27 Sep 2014 ESMO 2014: TAS-102 Improves Overall- and Progression-Free Survival in Patients With Metastatic Colorectal Cancer Refractory to Standard Therapies Gastrointestinal cancers - Anticancer agents & Biologic therapy
27 Sep 2014 ESMO 2014 Press Release: Anamorelin Shown to Improve Appetite and Body Mass in Patients with Cancer Anorexia-Cachexia Palliative and supportive care - Lung and other thoracic tumours
27 Sep 2014 ESMO 2014 Press Release: Cancer During Pregnancy: Chemotherapy and Radiotherapy are Safe for Babies, Studies Show Cancer in Special Situations
27 Sep 2014 ESMO 2014 Press Release: Rolapitant Reduces Nausea and Vomiting in Phase III Trial Palliative and supportive care
27 Sep 2014 ESMO 2014 Press Release: Second-Line Afatinib Significantly Improves Progression-Free Survival in Recurrent or Metastatic Head and Neck Cancer, Phase III Trial Shows Head and neck cancers - Anticancer agents & Biologic therapy
27 Sep 2014 ESMO 2014 Press Release: French Studies Measure Benefits of Colorectal Cancer Screening Cancer prevention - Gastrointestinal cancers
27 Sep 2014 ESMO 2014 Pathway of the Day: RAS/RAF/MEK/ERK Pathology/Molecular biology
26 Sep 2014 ESMO 2014 Press Release: More Than 70% of Young Oncologists in Europe Suffer Symptoms of Burnout Bioethics, legal and economic issues
26 Sep 2014 ESMO 2014 Press Release: Discrepancies in Access to New Cancer Drugs Revealed Breast cancer - Bioethics, legal and economic issues